
Metabolic treatment of cancer and other disorders
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 65 | Founded | a year ago | Last Issue | 7 days ago |
| Active | |||||

Subscribe now
The ASCO Clinical Notice reflects a cautious, evidence-based position consistent with current oncology guidelines, emphasizing that neither ivermectin nor fenbendazole has been establish...
Subscribe now
Luteolin has one of the broadest anticancer profiles among naturally occurring flavonoids. Like curcumin and quercetin, it is not tumor-specific but instead targets multiple “hallmarks of cancer,” including proliferation, inf...
Subscribe now
Several recent patient reports have prompted me to reexamine one aspect of the 5-Axis Metabolic Pressure protocol: the monthly cycling of doxycycline and mebendazole. Several patients were reported to have experienced disease...
Subscribe now
What follows is Alex and Chris’s story, told in their own words. I am deeply grateful to both of them for allowing me to share their remarkable journey. Their experience is both inspiring and instru...
My previous post entitled “The Ivermectin and Mebendazole Dosing Question: What Is the Optimal Dose for Cancer?” reviewed the dosing of Ivermectin and Mebendazole and the toxicity of each drug. I provided suggested dosages (see table below)...
Subscribers, engagement, traffic and sponsorship for Paul Marik.
| Subscribers | Engagement | 88 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where Paul Marik ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 82 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #94 | |
| #19 |
The writers behind this newsletter.
The treatment of Cancer and Metabolic diseases using diet, repurposed pharmaceuticals, and targeted nutraceuticals.
You can find recent issues that have been published by Paul Marik on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Paul Marik, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Paul Marik as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Paul Marik using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Paul Marik. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.